Stock MIST MILESTONE PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Milestone Pharmaceuticals Inc.

Equities

MIST

CA59935V1076

Delayed Nasdaq
Other stock markets
 11:52:46 2024-05-17 EDT 		5-day change 1st Jan Change
1.75 USD 0.00% Intraday chart for Milestone Pharmaceuticals Inc. +2.94% +4.78%
05-13 Milestone Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-08 Milestone Pharmaceuticals Announces Etripamil Data Demonstrating Patients? Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Milestone Pharmaceuticals Inc. Elects Seth H.Z. Fischer to the Board
CI
Milestone Pharmaceuticals Inc. Announces the Retirement of Francis Plat as Chief Scientific Officer, Effective December 31, 2022
CI
Milestone Pharmaceuticals Announces Management Changes
CI
Milestone Pharmaceuticals Inc. Announces Board Changes
CI
Milestone Pharmaceuticals Inc. Appoints Lisa Giles and Robert Wills to Board of Directors, Effective October 1, 2020
CI
Milestone Pharmaceuticals Inc Announces Promotion of Jeff Nelson to Chief Operating Officer
CI
Milestone Pharmaceuticals Inc. Announces Resignation of Marco Boorsma from its Board of Directors
CI
Milestone Pharmaceuticals Inc. Appoints Richard C. Pasternak to its Board of Directors and a Member of the Company's Compensation Committee
CI
Milestone Pharmaceuticals Inc. Announces Executive Changes
CI
Milestone Pharmaceuticals Inc. Announces Resignation of Nilesh Kumar from the Board of Directors
CI
Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development
CI
Milestone Pharmaceuticals Appoints Paul Edick as Chairman of Board of Directors
CI
Milestone Pharmaceuticals Inc. Appoints Michael Tomsicek to Board of Directors and Chairman of Audit Committee
CI
Milestone Pharmaceuticals USA Names Lorenz Muller as Chief Commercial Officer
CI
Milestone Pharmaceuticals Appoint Board of Directors
CI
Milestone Pharmaceuticals Inc. Announces United States Adopted Name Approval of Generic Name "Etripamil" for Phase 2 Clinical Development Product
CI
Milestone Pharmaceuticals Inc. Appoints Francis Plat as Chief Medical Officer
CI
Milestone Pharmaceuticals Inc. Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MIST Stock
  4. News Milestone Pharmaceuticals Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW